# Safe Delivery of Thrombolytic Treatment for Pulmonary Embolism Using ClotPro® Viscoelastic Tests

> **NCT06667882** · NA · COMPLETED · sponsor: **Semmelweis University** · enrollment: 33 (actual)

## Conditions studied

- Pulmonary Embolism Subacute Massive
- Complication of Treatment
- Fibrinolysis; Hemorrhage

## Interventions

- **DRUG:** Alteplase Injectable Product

## Key facts

- **NCT ID:** NCT06667882
- **Lead sponsor:** Semmelweis University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-17
- **Primary completion:** 2024-10-24
- **Final completion:** 2024-10-24
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2024-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06667882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06667882, "Safe Delivery of Thrombolytic Treatment for Pulmonary Embolism Using ClotPro® Viscoelastic Tests". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06667882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*